Fibrin D-dimer levels in atrial fibrillation as an index of thrombogenesis: A possible test to exclude left atrial thrombus?

American Journal of Cardiology

Volumn 92, Issue 1, 2003, Pages 47-49

  Tayebjee, Muzahir H ^a   Lip, Gregory Y H ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

D DIMER;

CARDIOVERSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY RISK; DIAGNOSTIC ACCURACY; DISEASE MARKER; DOUBLE BLIND PROCEDURE; EDITORIAL; FIBRINOGEN BLOOD LEVEL; HEART ATRIUM FIBRILLATION; HEART ATRIUM THROMBOSIS; HUMAN; INTERMETHOD COMPARISON; LABORATORY TEST; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; SCREENING TEST; THROMBOGENESIS; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 0037524327     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(03)00463-6     Document Type: Note

References (14)

1. Lip G.Y.H. Does atrial fibrillation confer a hypercoagulable state? Lancet. 346:1995;1313-1314.
2. Aschenberg W., Schulter M., Krerner P., Schroder E., Siglow V., Bleifeld W. Transesophageal two-dimensional echocardiography for the detection of left atrial appendage thrombus. J Am Coll Cardiol. 7:1986;163-166.
3. Lip G.Y.H., Hart R.G., Conway D. Antithrombotic therapy for atrial fibrillation. Br Med J. 325:2002;1022-1025.
4. Kelly J., Rudd A., Lewis R., Hunt B.J. Plasma D-dimers in the diagnosis of venous thromboembolism. Arch Intern Med. 162:2002;747-756.
5. Lowe G.D.O., Rumley A., Yarnell J.W.G., Sweetnam P.M., Thomas H.F. Fibrin D-dimer, von Willebrand factor and tissue plasminogen activator antigens are predictors of major ischaemic heart disease the Caerphilly Study . Blood Coagulation and Fibrinolysis. 6:1995;156-157.
6. Woodburn K., Lowe G., Rumley A., Love J., Pollock J. Relation of hemostatic, fibrinolytic, and rheological variables to the angiographic extent of peripheral arterial occlusive disease. Int Angiol. 14:1995;346-352.
7. Lip G.Y.H., Lip P., Zarifis J., Watson R.D., Bareford D., Lowe G.D., Beevers D.G. Fibrin D-dimer and thrombomodulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultra-low-dose warfarin and aspirin. Circulation. 94:1996;425-431.
8. Lip G.Y.H., Rumley A., Dunn F., Lowe G. Plasma fibrinogen and fibrin D-dimer levels in paroxysmal atrial fibrillation effects of cardioversion to sinus rhythm . Int J Cardiol. 51:1995;245-251.
9. Somlói M., Tomcsáyi J., Nagy E., Bodó I., Bezzegh A. D-dimer determination as a screening tool to exclude atrial thrombi in atrial fibrillation. Am J Cardiol. 92:2003;85-87.
10. Letac B. Transesophageal echocardiography versus oral anticoagulation before electrical cardioversion of atrial fibrillation what about atrial clot size? J Am Coll Cardiol. 27:1996;251-253.
11. Corrado G., Taedo G., Beretta S., Tagliagambe L.M., Manzillo G.F., Spata M., Santarone M. Atrial thrombi resolution after prolonged anticoagulation in patients with atrial fibrillation. Chest. 115:1999;140-143.
12. Turpie A.G.G., Chin B.S.P., Lip G.Y.H. Venous thromboembolism treatment strategies . Br Med J. 325:2002;948-950.
13. Lip G.Y.H., Lowe G., Metcalfe M., Rumley A., Dunn F. Effects of warfarin therapy on plasma fibrinogen, von Willebrand factor, and fibrin D-dimer in left ventricular dysfunction secondary to coronary artery disease with and without aneurysms. Am J Cardiol. 76:1995;453-458.
14. Plutzky J. Inflammatory pathways in atherosclerosis and acute coronary syndromes. Am J Cardiol. 88:(suppl):2001;10K-15K.